APL-5125
Drug timelines are a Plus or Pro feature.
1 regulatory and trial event tracked for APL-5125, covering 2026-01-07 to 2026-01-07. Get the full timeline:
Most recent: Clinical Trial Update: A Study to Investigate APL-5125 in Adults With Advanced Solid Tumors [Phase 1, Phase 2]